#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute promyelocytic leukaemia Angiosarcoma non-metastatic Fibrosarcoma Oesophageal adenocarcinoma stage III Basal cell naevus syndrome Eosinophilic oesophagitis Prader-Willi syndrome Metastatic malignant melanoma Anti-myelin-associated glycoprotein associated polyneuropathy Arrhythmogenic right ventricular dysplasia Ewing's sarcoma recurrent Pulmonary hypertension Pleural mesothelioma Pseudomyxoma peritonei Primary hyperoxaluria More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Basic Information Cystic fibrosis – Basic Information Phenylketonuria – Basic Information Mantle cell lymphoma stage IV – Trials in Disease Synovial sarcoma recurrent – Treatment Indolent systemic mastocytosis Primary biliary cholangitis – Life with Disease Hereditary ataxia Pulmonary fibrosis – Basic Information Marfan’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ab-1002 Doravirine Tralokinumab Crinecerfont Abc-15Bo-116 Spartalizumab Sufentanil Afimetoran Besilate Dihydrate Paeonol Tisagenlecleucel Glpg3667 Fumarate Magrolimab ZILEBESIRAN Mva-209-Fsp-B1 Thiamazole Ganciclovir RNMB2 Upacicalcet Sodium Hydrate Prilocaine Ergocalciferol Bp More therapies…

    Learn about Your Condition

    Muscular dystrophy Systemic scleroderma Vascular graft thrombosis Urea cycle disorder Yellow fever Epithelioid sarcoma Proteinuria Fragile X syndrome Peyronie's disease Methylmalonic acidaemia Cerebral palsy Undifferentiated sarcoma Coagulopathy Leiomyosarcoma recurrent Oesophageal achalasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Esketamine Hydrochloride and Sodium Chloride for Patients with Severe Acute Brain Injury

    Recruiting

    3 1 1
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Sodium Chloride
    Denmark

  • Study on the Effects of Sodium Lactate and Electrolyte Solution in Comatose Patients After Cardiac Arrest

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    • Post cardiac arrest syndrome
    • Reperfusion injury
    Investigated Drugs:
    • Sodium Lactate
    • Magnesium Chloride Hexahydrate
    • Potassium Chloride
    Belgium

  • Study of pegcetacoplan safety and effectiveness in adolescents aged 12-17 with paroxysmal nocturnal hemoglobinuria

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Pegcetacoplan
    The Netherlands Spain

  • Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Vidofludimus Calcium
    Bulgaria Czechia Germany The Netherlands Poland Romania

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • CEFTAROLINE FOSAMIL
    • Clindamycin Hydrochloride
    France

  • Study on Cluster Headache Using Befiradol (18F) for Patients with Episodic Symptoms

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Befiradol (18F)
    France
Previous Page
1 … 365 366 367 368 369 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!